Bio-Techne Corp (NAS:TECH)
$ 83.805 0.965 (1.16%) Market Cap: 13.21 Bil Enterprise Value: 13.40 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at UBS Global Healthcare Conference Transcript

May 22, 2019 / 01:00PM GMT
Release Date Price: $50.51 (+0.47%)
Dan Brennand;
UBS Investment Bank, Research Division

Welcome. Day 3 of the UBS Global Healthcare Conference. My name is Dan Brennand. I cover tools, diagnostics and the pharma service space. Very pleased to have with me on stage Chuck Kummeth, CEO of Bio-Techne. In the audience, we have David Clair as well from IR.

Listen, we are going to have a series of questions to go through with Chuck, and certainly, we welcome any audience participation. So during the presentation, I'll look up and feel free to just chime in. But before we do that, I need to point everyone to the UBS website, www.ubs.com, to look for analyst disclaimers.

So with that, Chuck, welcome. Very pleased to have you here. I thought we could just start out, Chuck, just by talking about Bio-Techne's overall growth profile. I know you've discussed kind of the double-digit growth profile as a target. I think growth year-to-date has been around that level. Just kind of wondering -- well, I don't know if you wanted to go through the slides first.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot